Drug(薬物リスト) DrugBank | All Description Patterns

e.g. "Sirolimus", "アダリムマブ"

ABCDEFGH I JKLMNOPQRSTUVWXYZother

92 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG
💬 Info on mouse-over
KEGG GENES
💬 Info on mouse-over
KEGG PATHWAY 指定難病告示番号
💬 Info on mouse-over
1 2011-2012 seasonal flu vaccine intramuscular - - - - 2件:  3 , 113💬
2 2011-2012 seasonal flu vaccine subcutaneous - - - - 2件:  3 , 113💬
3 4-aminopyridine Dalfampridine 1件: D04127💬 4件: KCNA4, KCNC3, KCND2, KCND3💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 2件:  3 , 13💬
4 4-cholesten-3-one, oxime - - - - 2件:  2 ,  3 💬
5 4-cholesten-3-one,oxime - - - - 1件:  3 💬
6 Adipose derived mesenchymal stem cell - - - - 1件:  3 💬
7 Air - - - - 7件:  3 , 51, 58, 85, 97, 193, 299💬
8 Amifampridine Amifampridine 1件: D10228💬 4件: KCNA4, KCNC3, KCND2, KCND3💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 3件:  3 , 11, 12💬
9 Amifampridine phosphate Amifampridine 1件: D10228💬 4件: KCNA4, KCNC3, KCND2, KCND3💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 3件:  3 , 11, 12💬
10 Amifampridine phosphate 10 mg oral tablet Amifampridine 1件: D10228💬 4件: KCNA4, KCNC3, KCND2, KCND3💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 1件:  3 💬
11 Avxs-101 - - - - 1件:  3 💬
12 Avxs-101 (previously known as scaav9.cb.smn) - - - - 1件:  3 💬
13 Biocarn - - - - 1件:  3 💬
14 Branaplam Branaplam - - - 1件:  3 💬
15 Celecoxib Celecoxib 1件: D00567💬 1件: PTGS2💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 9件:  2 ,  3 , 34, 46, 70, 89, 161, 171, 271💬
16 Gh - - - - 1件:  3 💬
17 Human anti-promyostatin monoclonal antibody - - - - 1件:  3 💬
18 Hydroxyurea Hydroxyurea 1件: D00341💬 1件: RRM2💬 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 8件:  3 , 13, 19, 20, 65, 85, 86, 284💬
19 Isis 396443 - - - - 1件:  3 💬
20 Isis 396443 (biib058) - - - - 1件:  3 💬
21 Isis 396443, biib058 - - - - 1件:  3 💬
22 Itraconazole Itraconazole 1件: D00350💬 - - 4件:  3 , 65, 227, 299💬
23 Leuprolide Leuprolide 2件: D00989, D08113💬 1件: GNRHR💬 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 5件:  1 ,  2 ,  3 , 51, 76💬
24 Levocarnitine Levocarnitine 3件: D02030, D02176, D04713💬 - - 3件:  3 , 53, 97💬
25 Lmi070 - - - - 1件:  3 💬
26 Mestinon - - - - 3件:  3 ,  6 , 11💬
27 Midazolam Midazolam 3件: D00550, D00696, D05028💬 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ💬 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 11件:  2 ,  3 ,  6 , 13, 21, 46, 70, 96, 97, 231, 298💬
28 N.a. - - - - 10件:  3 ,  6 ,  8 , 13, 46, 96, 97, 240, 256, 271💬
29 Nerve growth factor Nerve Growth Factor - - - 2件:  3 , 90💬
30 Norditropin simplexx - - - - 4件:  3 , 78, 193, 195💬
31 Norditropin simplexx 15 mg/1.5 ml - - - - 1件:  3 💬
32 Nursinersen - - - - 1件:  3 💬
33 Nusinersen Nusinersen 1件: D10881💬 1件: SMN2💬 1件: RNA transport 1件:  3 💬
34 Nusinersen injectable product Nusinersen 1件: D10881💬 1件: SMN2💬 1件: RNA transport 1件:  3 💬
35 Nusinersen sodium Nusinersen 1件: D10881💬 1件: SMN2💬 1件: RNA transport 1件:  3 💬
36 Nusinersen treatments Nusinersen 1件: D10881💬 1件: SMN2💬 1件: RNA transport 1件:  3 💬
37 Olesoxime - - - - 2件:  2 ,  3 💬
38 Onasemnogene abeparvovec Onasemnogene abeparvovec 1件: D11559💬 1件: SMN1💬 1件: RNA transport 1件:  3 💬
39 Onasemnogene abeparvovec-xioi Onasemnogene abeparvovec 1件: D11559💬 1件: SMN1💬 1件: RNA transport 1件:  3 💬
40 Orfiril saft - - - - 1件:  3 💬
41 Other: monthly assessments of functional motor abilities by a trained therapist - - - - 1件:  3 💬
42 Other: prospective observational registry - - - - 1件:  3 💬
43 Paracetamol Acetaminophen 1件: D00217💬 2件: PTGS1, PTGS2💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 5件:  3 ,  6 , 13, 35, 46💬
44 Paracetamol 120mg/5ml oral suspension Acetaminophen 1件: D00217💬 2件: PTGS1, PTGS2💬 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件:  3 💬
45 Phenylbutyrate Phenylbutyric acid 1件: D05868💬 - - 11件:  2 ,  3 ,  6 ,  8 , 15, 93, 94, 244, 251, 297, 299💬
46 Phosphate Phosphate ion - - - 30件:  2 ,  3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299💬
47 Placebo - - - - 26件:  3 ,  5 ,  6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276💬
48 Procedure: air stacking manuever - - - - 1件:  3 💬
49 Procedure: sham procedure - - - - 1件:  3 💬
50 Pyridostigmine Pyridostigmine 1件: D00487💬 1件: ACHE💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 4件:  3 ,  6 , 11, 256💬
51 Pyridostigmine bromide Pyridostigmine 1件: D00487💬 1件: ACHE💬 2件: Cholinergic synapse, Glycerophospholipid metabolism 3件:  3 ,  6 , 256💬
52 Reldesemtiv Reldesemtiv 1件: D11363💬 1件: TNNC2💬 1件: Calcium signaling pathway 2件:  2 ,  3 💬
53 Reldesemtiv 150 mg Reldesemtiv 1件: D11363💬 1件: TNNC2💬 1件: Calcium signaling pathway 1件:  3 💬
54 Reldesemtiv 450 mg Reldesemtiv 1件: D11363💬 1件: TNNC2💬 1件: Calcium signaling pathway 1件:  3 💬
55 Riluzole Riluzole 1件: D00775💬 14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D💬 23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 8件:  2 ,  3 ,  5 ,  8 , 13, 17, 18, 206💬
56 Risdiplam Risdiplam 1件: D11406💬 1件: SMN2💬 1件: RNA transport 1件:  3 💬
57 Ro6885247 - - - - 1件:  3 💬
58 Ro6885247/f02 - - - - 1件:  3 💬
59 Ro6885247/f03 - - - - 1件:  3 💬
60 Ro7034067 - - - - 1件:  3 💬
61 Ro7034067 / f12 - - - - 1件:  3 💬
62 Ro7034067 / f13 - - - - 1件:  3 💬
63 Ro7034067/f06 + solvente (ro - - - - 1件:  3 💬
64 Ro7034067/f06 with solvent (ro7034067/f08) - - - - 1件:  3 💬
65 Ro7034067/f07 + solvente (ro - - - - 1件:  3 💬
66 Ro7034067/f07 with solvent (ro7034067/f09) - - - - 1件:  3 💬
67 Ro7034067/f12 - - - - 1件:  3 💬
68 Ro7034067/f13 - - - - 1件:  3 💬
69 Ro7090919 - - - - 1件:  3 💬
70 Rvg 03820 - - - - 1件:  3 💬
71 Salbutamol Salbutamol 1件: D02147💬 1件: ADRB2💬 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 9件:  3 , 11, 49, 85, 86, 111, 228, 256, 299💬
72 Sesame oil Sesame oil 1件: D03314💬 - - 1件:  3 💬
73 Sesame oil, refined Sesame oil 1件: D03314💬 - - 1件:  3 💬
74 Smart - - - - 1件:  3 💬
75 Sodium phenylbutyrate Phenylbutyric acid 1件: D05868💬 - - 4件:  2 ,  3 ,  8 , 251💬
76 Sodium phenylbutyrate (napb) Phenylbutyric acid 1件: D05868💬 - - 1件:  3 💬
77 Somatotropin Somatotropin 1件: D02691💬 1件: GHR💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 3件:  3 , 78, 236💬
78 Somatropin Somatotropin 1件: D02691💬 1件: GHR💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 16件:  2 ,  3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299💬
79 Spinraza - - - - 1件:  3 💬
80 Srk-015 - - - - 1件:  3 💬
81 Survival of motor neuron 2 (smn2) splicing modulator antisense oligonucleotide - - - - 1件:  3 💬
82 Testosterone Testosterone 6件: D00075, D00957, D00958, D00959, D06085, D06087💬 1件: AR💬 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer 8件:  1 ,  2 ,  3 , 13, 60, 78, 113, 265💬
83 Tro19622 TRO19622 - - - 3件:  2 ,  3 , 13💬
84 Valproate Valproic acid 1件: D00399💬 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2💬 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 6件:  2 ,  3 , 90, 102, 233, 256💬
85 Valproate sodium Valproic acid 1件: D00399💬 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2💬 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件:  3 💬
86 Valproate, levocarnitine Levocarnitine 4件: D00399, D02030, D02176, D04713💬 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2💬 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件:  3 💬
87 Valproic acid Valproic acid 1件: D00399💬 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2💬 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 10件:  3 ,  5 , 26, 34, 65, 89, 90, 222, 256, 331💬
88 Valproic acid (vpa) Valproic acid 1件: D00399💬 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2💬 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件:  3 💬
89 Valproic acid and levocarnitine Levocarnitine 4件: D00399, D02030, D02176, D04713💬 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2💬 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 1件:  3 💬
90 Volmax*30cpr 4mg r.p. - - - - 1件:  3 💬
91 Vpa - - - - 1件:  3 💬
92 Zolgensma - - - - 1件:  3 💬

先頭へ